By Mary Jane Minkin, MDClinical Professor, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine; and Obstetrics, Gynecology and Menopause Physician, PC, New Haven, CT.
I knew that I would have problems with our new electronic medical record (EMR) system on the first day of training. The initial training was conducted by a programmatic, not medically trained “yuppette” from the IT Department, who extolled to a 60-year-old Mac user the wonders of the EMR system: you should right click here, single click there (oops, don’t double click!), and then enter some esoteric bit of medical history. [More]
By Ralph Tarantino, PhD
Pharmaceutical Consultant and Principal, SteriTech Solutions, LLCMiddletown, NJ
Most would agree that mapping of the human genome during the last few years of the 20th century was a key technological advance in a century that saw the most technological advances in history. Knowledge of the human genome makes pharmacogenomics possible, and pharmacogenomics makes personalized medicines possible. Personalized medicine—hype not withstanding—is a model for pharmacotherapeutics that cannot be ignored by those interested in advancements in the treatment of disease. It most often refers to use of an individual’s genetic information to optimize treatment or prevent disease for that individual. Crizotinib (Xalkori) and vemurafenib (Zelboraf) are notable personalized medicines approved by the FDA in 2011. [More]